Spectrum Health Ventures

SpendMend is a healthcare-focused company that helps organizations identify and mitigate financial leakage through its tech-enabled platform. It discovers payment errors and contract non-compliance within operating expenses, enabling clients to optimize cost cycle management and reduce over-payments.

KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

Professional Credentials Exchange, LLC is a Tampa, Florida-based company that operates a blockchain-enabled platform designed for the verification and monetization of professional credentials within the healthcare sector. Its primary offering, ProCredEx, serves as a digital marketplace where healthcare organizations can securely share, exchange, and acquire verified credentialing data. This innovative platform aims to streamline the credentialing process, reducing the cost and complexity traditionally associated with verifying healthcare professionals. By creating a network that connects various stakeholders in the industry, Professional Credentials Exchange enhances the efficiency of credentialing transactions, allowing members to quickly access verified information and facilitating faster onboarding of clinicians. The company was established in 2018 and focuses on transforming the landscape of credential verification in the U.S. healthcare market.

VyncaCare provides palliative care, advanced care planning, and enhanced care management services.

Lumere, Inc. is a Chicago-based company that offers a cloud-based platform designed to assist hospitals and physicians in reducing clinical variation and unnecessary costs associated with medical devices and pharmaceuticals. The platform features tools such as Product Introduction Management, which redefines the device vetting process through analysis of clinical evidence and best practices; Category Optimization, which integrates clinical insights with data from health systems to identify potential cost savings; and Variation Management, which analyzes procedural utilization data to evaluate how medical devices are used. Additionally, Utilization Management combines clinical information with prescriber patterns to optimize drug spending and address inappropriate usage. Lumere also provides physician advisory services to ensure alignment between healthcare providers and hospital management. Founded in 2012, Lumere was previously known as Procured, Inc., and operates as a subsidiary of Global Healthcare Exchange, LLC.

ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly targeting conditions related to the heart, liver, and neurodegeneration. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology that allows for the differentiation of cells into any type found in the body. This technology is employed to test drug efficacy, screen for medication toxicity, and create personalized treatment pathways. The company offers a range of products, including LifeProfiles, which provides genetic insights related to fitness, metabolism, and exercise recovery; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.

ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly targeting conditions related to the heart, liver, and neurodegeneration. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology that allows for the differentiation of cells into any type found in the body. This technology is employed to test drug efficacy, screen for medication toxicity, and create personalized treatment pathways. The company offers a range of products, including LifeProfiles, which provides genetic insights related to fitness, metabolism, and exercise recovery; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.